Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Université de Montréal

$125,600.00

Identification of early markers of epigenetic disorders in bovine production

FY 2024-25

Summary
In the past decades, North American bovine producers have largely turned to embryo production techniques to achieve specific traits such as feed efficiency, milk production and general health. In vitro produced embryos generated from donors of carefully selected genetic background are implanted in recipient females, resulting in increased production, reduced generation time and overall improvement upon a herd's genetic traits. Approximately 45% of commercial embryo transfer activity in the world originates from North America. While Canada accounts for under 2% of global dairy cattle, it supplies over 20% of the world market. However, in vitro produced embryos are associated with larger birth weights and increased rates of perinatal anomalies. Epigenetics is the combination of specific modifications on the genome itself or on proteins associated with DNA. The combination of these epigenetic modifications controls which genes are expressed or not in a manner independent of the genetic sequence. In complex organisms such as cows, it is these epigenetic modifications that provide information on how specific cell types should behave. Assisted reproductive techniques, including those specific manipulations involved in in vitro embryo production, are performed at developmental stages where the epigenetic marks are broadly remodeled on the genome. Thus, one of the proposed causes of the increased rate of anomalies observed in in vitro production is the introduction of "epigenetic" disorders. The goal of this project is to identify markers indicative of epigenetic anomalies prior to embryo transfer. Our results will lead to a further improvement upon the embryo screening process through the identification of an unfavorable epigenome, securing us as leaders in the field of in vitro bovine embryo production. Advantages for Canadian breeders include an increased value of animals entering the genetic market and a multiplication of these high value (epi)genomes within the Canadian market.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
581554-2023
Name nom
Brind'Amour, Julie J
Department département
Médecine vétérinaire, faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
125600
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5510
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal production and breeding
Research subject fr
Production et reproduction animales
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Identification of early markers of epigenetic disorders in bovine production
Keywords
bovine; developmental disorders; embryo; epigenomics; in vitro production; proxy markers; transcriptomics
Application summary
In the past decades, North American bovine producers have largely turned to embryo production techniques to achieve specific traits such as feed efficiency, milk production and general health. In vitro produced embryos generated from donors of carefully selected genetic background are implanted in recipient females, resulting in increased production, reduced generation time and overall improvement upon a herd's genetic traits. Approximately 45% of commercial embryo transfer activity in the world originates from North America. While Canada accounts for under 2% of global dairy cattle, it supplies over 20% of the world market. However, in vitro produced embryos are associated with larger birth weights and increased rates of perinatal anomalies. Epigenetics is the combination of specific modifications on the genome itself or on proteins associated with DNA. The combination of these epigenetic modifications controls which genes are expressed or not in a manner independent of the genetic sequence. In complex organisms such as cows, it is these epigenetic modifications that provide information on how specific cell types should behave. Assisted reproductive techniques, including those specific manipulations involved in in vitro embryo production, are performed at developmental stages where the epigenetic marks are broadly remodeled on the genome. Thus, one of the proposed causes of the increased rate of anomalies observed in in vitro production is the introduction of "epigenetic" disorders. The goal of this project is to identify markers indicative of epigenetic anomalies prior to embryo transfer. Our results will lead to a further improvement upon the embryo screening process through the identification of an unfavorable epigenome, securing us as leaders in the field of in vitro bovine embryo production. Advantages for Canadian breeders include an increased value of animals entering the genetic market and a multiplication of these high value (epi)genomes within the Canadian market.
Université de Montréal - $125,600 Grant (2024-25) | Canada Spends